Septerna Expands Leadership with Mark A. Wilson as Chief Legal Officer
Septerna, Inc. (Nasdaq: SEPN), a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) drug discovery, today announced the appointment of Mark...